Market Overview

UPDATE: Goldman Sachs Raises PT on Monsanto Company on 2Q13 EPS

Share:
Related MON
Q3 13F Roundup: How Buffett, Einhorn, Paulson, And Others Adjusted Their Portfolio
6 Stocks To Watch For October 4, 2017
Missouri to restrict use of weedkiller linked to crop damage (Seeking Alpha)

In a report published Friday, Goldman Sachs analyst Robert Koort reiterated a Buy rating on Monsanto Company (NYSE: MON), and raised the price target from $116.00 to $122.00.

In the report, Koort noted, “MON reported 2Q13 EPS of $2.73 vs. our/Street estimates of $2.57/$2.56 and raised FY2013 EPS guidance by $0.10 to $4.40-$4.50. Mgmt also guided new product (reduced refuge and RR2) acres to the high end of their prior ranges and expressed confidence in Intacta commercialization in Brazil in FY2014 and Argentina in FY2015. The earnings beat follows last week's announcement that DD will license MON's RR2 soybean trait beginning in 2014, which significantly reduces competitive threats and de-risks future earnings, in our opinion.”

Monsanto Company closed on Thursday at $105.74.

Latest Ratings for MON

DateFirmActionFromTo
Oct 2017Wells FargoMaintainsMarket Perform
Oct 2017BarclaysMaintainsEqual-Weight
Aug 2017UBSDowngradesBuyNeutral

View More Analyst Ratings for MON
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Price Target Analyst Ratings

 

Related Articles (MON)

View Comments and Join the Discussion!

Partner Center